Population Pharmacokinetics of Fosdagrocorat (PF‐04171327), a Dissociated Glucocorticoid Receptor Agonist, in Patients With Rheumatoid Arthritis

Publisher： John Wiley & Sons Inc

E-ISSN： 1752-8062|11|1|54-62

ISSN： 1752-8054

Source： CLINICAL AND TRANSLATIONAL SCIENCE (ELECTRONIC), Vol.11, Iss.1, 2018-01, pp. : 54-62

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Serum levels of parathyroid hormone and markers of bone metabolism in patients with rheumatoid arthritis. Relationship to disease activity and glucocorticoid treatment

By Jensen T.   Hansen M.   Madsen J. C.   Kollerup G.   Stoltenberg M.   Florescu A.   Schwarz P.  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 61, Iss. 6, 2001-09 ,pp. : 491-501

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab in rheumatoid arthritis

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 2, 2015-02 ,pp. : 286-297

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reversing Vascular Dysfunction in Rheumatoid Arthritis: Improved Augmentation Index but Not Endothelial Function With Peroxisome Proliferator–Activated Receptor γ Agonist Therapy

By  

ARTHRITIS & RHEUMATOLOGY, Vol. 66, Iss. 9, 2014-09 ,pp. : 2331-2338

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hearing status in patients with rheumatoid arthritis

By  

Journal of Laryngology and Otology, Vol. 131, Iss. 10, 2017-10 ,pp. : 895-899

Cambridge University Press

Access to resources Recommend Favorite

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis

By Robak T.   Gladalska A.   Stepien H.   Robak E.  

Mediators of Inflammation, Vol. 7, Iss. 5, 1998-10 ,pp. : 347-353

Informa Healthcare

Access to resources Recommend Favorite